The TIMER 2.0 database displayed that the expression of GPX4 was substantially upregulated in Bladder Urothelial Carcinoma, Breast invasive carcinoma, COAD, Esophageal Carcinoma, etc. (Fig. 1A). This evidence concerns the gene GPX4 and bladder transitional cell carcinoma.